Subscribe free to our newsletters via your
. Medical and Hospital News .




INTERN DAILY
New patenting guidelines are needed for biotechnology
by Staff Writers
Houston TX (SPX) Apr 29, 2014


Biotechnological inventions have been patented for several decades, though the criteria for patent eligibility have been refined through numerous court decisions.

Biotechnology scientists must be aware of the broad patent landscape and push for new patent and licensing guidelines, according to a new paper from Rice University's Baker Institute for Public Policy.

Published in the current issue of the journal Regenerative Medicine, the paper is based on the June 2013 U.S. Supreme Court ruling in the case Association for Molecular Pathology (AMP) v. Myriad Genetics that naturally occurring genes are unpatentable. The court case and rulings garnered discussion in the public about patenting biological materials.

"The AMP v. Myriad Genetics case raises questions about the patent system," said Kirstin Matthews, the Baker Institute fellow in science and technology policy and an expert on ethical and policy issues related to biomedical research and development. She co-authored the paper with Maude Rowland Cuchiara, the Baker Institute scholar for science and technology policy. The paper has timely significance in light of President Barack Obama's recent announcements on reforming the nation's patent process, including an initiative announced in February to "crowdsource" the review of patents.

"There are not many opportunities to challenge patents once they have been granted, and the options that are available are costly and mostly limited to lawsuits," Matthews said. Judges typically do not have the scientific knowledge to understand some of the technical arguments that are made in their courts, she said.

"It may be better, as President Obama has proposed, to revise patenting guidelines at the U.S. Patent and Trademark Office based on feedback from scientists, engineers, ethicists and policy scholars as opposed to leaving it up to the courts."

Until the Supreme Court's decision, Myriad Genetics was the only company in the U.S. that could legally conduct diagnostic testing for BRCA 1 and 2, genes that are linked to familial breast and ovarian cancer. The company was granted the patents in 1998 and 2000, respectively. Myriad chose not to license the patents and harshly pursued anyone who infringed on them.

"The patenting of the BRCA genes launched a raucous debate about the ability to patent life: How do we distinguish between what is simply discovered and what is truly 'made by man'?" the authors asked.

Biotechnological inventions have been patented for several decades, though the criteria for patent eligibility have been refined through numerous court decisions, according to the authors. One of the most influential was Diamond v. Chakrabarty, which determined that "anything under the sun made by man" could be patented, leading to the diverse biotechnology patent landscape seen today, the authors said. However, biotechnological patents must meet the same requirements as all other patents, and they cannot be laws of nature, physical phenomena or abstract ideas.

The authors said the ruling could affect the patentability of other biotechnologies, like stem cells, depending on how the ruling is interpreted. Stem cells, like genes, are also isolated from the body although they do require some manipulation after isolation. But it is likely that if stem cell patents include detailed procedures for the manipulations beyond isolation, they will be upheld. "However these types of patents could also be challenged for failing to meet other patenting requirements like non-obviousness - meaning that they were not really unique or original after all," the authors said.

Overall, it remains to be seen what impact the ruling in the AMP v. Myriad Genetics case will have on the biotech industry or if any patenting requirements will be changed in response to this or other court rulings, the authors said. So far, the patentability of biotechnological inventions appears to remain unaffected. "However, as more and more biotechnological inventions are patented, the line between what is and is not a 'product of nature' becomes blurred and will most likely continue to be decided in a courtroom," the authors said.

The authors suggest initial steps to address the current situation, including an outside review of patents before they are granted, reforming the rules of patent licensing to minimize restrictive practices and requiring detailed patent descriptions to prevent expensive and disruptive lawsuits.

"Moving forward, scientists must be aware of the broad patent landscape and push for new patent and licensing guidelines," the authors said. "This could keep patents out of court, make the patenting process more seamless and help to spur innovation."

.


Related Links
Rice University
Hospital and Medical News at InternDaily.com






Comment on this article via your Facebook, Yahoo, AOL, Hotmail login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle








INTERN DAILY
Biomedical applications of shape-memory polymers: How practically useful are they?
Beijing, China (SPX) Apr 29, 2014
Polymers that exhibit shape-memory effect (SME) are an important class of materials in medicine, especially for minimally invasive deployment of devices. Professor Subbu Venkatraman and his group from School of Materials Science and Engineering, Nanyang Technological University presented a review article surveying the clinical applications of the SME and addressing critically the question of its ... read more


INTERN DAILY
Nepal counts cost of damaging Everest debacle

Italy cruise ship removal project halted: media

Captain says warnings over Korean ferry ignored

How costly are natural hazards?

INTERN DAILY
Glonass Failure Caused by Faulty Software

Homegrown high-precision positioning system put to use

Russia eyes building Glonass stations in 36 countries

Turn your satnav ideas into business

INTERN DAILY
Genomic diversity and admixture differs for Stone-Age Scandinavian foragers and farmers

British designer Heatherwick seeks cities with 'human scale'

Prehistoric caribou hunting site discovered under Lake Huron

It's a bubble, but not as we know it

INTERN DAILY
Iconic Galapagos bird suffering population decline

Australian marine reserves provide safe passageway for endangered species

How a fish can fry

Important migratory corridor for endangered marine species off north-west Australia

INTERN DAILY
Mystery of the pandemic flu virus of 1918 solved by University of Arizona researchers

Two antibodies show promise blocking MERS virus

Decrease in large wildlife drives rodent-borne diseases

Re-Emergence of Ebola Focuses Need for Global Surveillance Strategies

INTERN DAILY
Church demolition illuminates China's religious tensions

US lawmaker urges China to expand religious freedoms

Most back to work after China shoe factory strike

China offers cash in Xinjiang for tips on beards: report

INTERN DAILY
Vietnam says 7 killed in shooting on China border

Kidnappers demand $11 mln for Chinese tourist

Malaysia kidnappers telephone Chinese victim's family

China presses Malaysia to rescue kidnapped tourist

INTERN DAILY
China poised to overtake US economy: World Bank ranking

US economy slows to a near-stall in first quarter

China house price increases slow in April: survey

Fujitsu swings back into the black




The content herein, unless otherwise known to be public domain, are Copyright 1995-2014 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement All images and articles appearing on Space Media Network have been edited or digitally altered in some way. Any requests to remove copyright material will be acted upon in a timely and appropriate manner. Any attempt to extort money from Space Media Network will be ignored and reported to Australian Law Enforcement Agencies as a potential case of financial fraud involving the use of a telephonic carriage device or postal service.